Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Chs (CHSCP) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Chs (CHSCP) over the last 16 years, with Q4 2025 value amounting to $844.8 million.

  • Chs' Change in Accured Expenses rose 3557.46% to $844.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$54.4 million, marking a year-over-year increase of 9338.44%. This contributed to the annual value of -$276.1 million for FY2025, which is 2915.32% down from last year.
  • As of Q4 2025, Chs' Change in Accured Expenses stood at $844.8 million, which was up 3557.46% from -$10.5 million recorded in Q3 2025.
  • Over the past 5 years, Chs' Change in Accured Expenses peaked at $1.4 billion during Q4 2022, and registered a low of -$1.5 billion during Q1 2024.
  • For the 5-year period, Chs' Change in Accured Expenses averaged around $50.8 million, with its median value being $98.4 million (2023).
  • In the last 5 years, Chs' Change in Accured Expenses soared by 48432.42% in 2021 and then plummeted by 27811.14% in 2022.
  • Over the past 5 years, Chs' Change in Accured Expenses (Quarter) stood at $1.4 billion in 2021, then grew by 1.49% to $1.4 billion in 2022, then fell by 14.51% to $1.2 billion in 2023, then tumbled by 49.44% to $623.1 million in 2024, then skyrocketed by 35.57% to $844.8 million in 2025.
  • Its last three reported values are $844.8 million in Q4 2025, -$10.5 million for Q3 2025, and $300.3 million during Q2 2025.